- Home
- SLS vs DUOT Comparison
SLS vs DUOT Comparison
Compare SLS & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLS | DUOT |
|---|---|---|
| Founded | 2012 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.0M | 210.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLS | DUOT |
|---|---|---|
| Price | $3.51 | $8.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 8.3M | 212.5K |
| Earning Date | 03-19-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,026,308.00 |
| Revenue This Year | N/A | $286.66 |
| Revenue Next Year | N/A | $44.93 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 159.00 |
| 52 Week Low | $0.95 | $3.84 |
| 52 Week High | $5.18 | $12.17 |
Technical Indicators
Market Signals| Indicator | SLS | DUOT |
|---|---|---|
| Relative Strength Index (RSI) | 45.61 | 36.54 |
| Support Level | $3.66 | $10.30 |
| Resistance Level | $4.20 | $10.00 |
| Average True Range (ATR) | 0.42 | 0.79 |
| MACD | -0.14 | -0.26 |
| Stochastic Oscillator | 1.48 | 7.05 |
Price Performance
Historical ComparisonAbout SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.
About DUOT Duos Technologies Group Inc.
Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.